TD Cowen Maintains Buy Rating on Twist Bioscience, Raises Target to $190
TD Cowen raised its price target on Twist Bioscience to $190 per share from $115 while maintaining its Buy rating.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
TD Cowen raised its price target on Twist Bioscience to $190 per share from $115 while maintaining its Buy rating.